Drugs / CASAD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01739634 | Nov 2012 → Dec 2013 | diarrheal disease, medullary thyroid gland carcinoma | Salient Pharmaceuticals Incorporated | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CASAD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01739634 ↗ |